| Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study | Thrombosis Research |  | | 2018 | 452 | 0 |
|
| Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency | Journal of thrombosis and haemostasis | | | 2013 | 674 | 0 |
|
| Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study | Journal of thrombosis and haemostasis | | | 2012 | 643 | 0 |
|
| Comparison of the Villalta post-thrombotic syndrome score in the ipsilateral vs. contralateral leg after a first unprovoked deep vein thrombosis | Journal of thrombosis and haemostasis | | | 2012 | 591 | 0 |
|
| Low prevalence of JAK2 V617F mutation in patients with first unprovoked venous thromboembolism | British journal of haematology | | | 2011 | 655 | 0 |
|
| Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism | Journal of thrombosis and haemostasis | | | 2010 | 616 | 0 |
|
| Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study | Thrombosis and haemostasis | | | 2010 | 649 | 0 |
|
| Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE | Thrombosis research | | | 2010 | 605 | 0 |
|
| Validation of a diagnostic approach to exclude recurrent venous thromboembolism | Journal of thrombosis and haemostasis | | | 2009 | 616 | 0 |
|
| Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy | CMAJ. Canadian Medical Association journal | | | 2008 | 578 | 0 |
|
